Methods of treating allergies using TGF-β1 and allergens
AssigneeYamanashi University
InventorAtsuhito Nakao
Life of this patent
Estimating the term…
Abstract
The invention provides an allergy prevention method or treatment method, diets and oral drugs enabling prevention/treatment of allergic symptoms without trouble such as systemic adverse reaction, immune deficiency and the like caused by transdermal/intravenous administration of TGF-β. The allergy prevention method or treatment method is to orally administer 100 μg/kg or more of transforming growth factor-beta (TGF-β) relative to a weight of an administration target body and thereby selectively suppress Th2 immune response, while with respect to the diets and oral drugs, the content is set to contain an effective amount of transforming growth factor-beta (TGF-β) therein.
Claims18
A method of treating a food allergy, wherein said method comprises:
- providing isolated transforming growth factor beta 1 (TGF-β1) in an amount of 100 μg/kg to 250 μg/kg, relative to a weight of an administration target body,
- providing a causal substance of allergy,
- combining the isolated TGF-β1 and causal substance of allergy,
- administering orally and simultaneously the combination to the administration target body in need thereof,
- wherein said causal substance of allergy is at least one food allergen and,
- wherein the method of treating allergy results in a non-transient immunological response;
- thereby treating the food allergy.
Dependencies are inferred from the claim text.